Literature DB >> 15963134

Treatment of pelvic fracture-related urethral trauma: a survey of current practice in the UK.

Daniela E Andrich1, Tamsin J Greenwell, Anthony R Mundy.   

Abstract

OBJECTIVE: To quantify experience of pelvic fracture-related urethral trauma (PFUT), a condition not often encountered and managed by urologists.
METHODS: The consultant urologists of the UK and Ireland were contacted informally to establish their experience with PFUT and its management, both immediate and delayed. In addition, particular individuals thought to have a specific interest in PFUT were targeted for more data.
RESULTS: The overall response rate was 49% (235 responders), representing 78% of urological departments, including all the targeted individuals. Of the responders, 129 (55%) had never seen PFUT in 1-25 years of consultant practice. Only four urologists (2% of responders) saw three or more cases a year. Another four (2%) saw one or two cases per year and the remaining 98 (41%) saw PFUT less frequently. Acutely, 69% of urologists who treated PFUT did so by placing a urethral catheter. Subsequent strictures were treated endoscopically for as long as this was possible. The other 31% inserted a suprapubic catheter and referred the patient for reconstructive surgery if needed. Those who used urethroplasty for strictures after PFUT were identified and targeted; half used urethral mobilization and spatulated anastomosis alone. Only three surgeons performed more than five procedures a year.
CONCLUSION: Whatever a specialist reconstructive unit might do, practice in the wider urological community is different. Even within specialized units, PFUT is rare and the surgical management is often significantly different from published 'expert' opinion.

Entities:  

Mesh:

Year:  2005        PMID: 15963134     DOI: 10.1111/j.1464-410X.2005.05580.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  Perineal midline vertical incision verses inverted-U incision in the urethroplasty: which is better?

Authors:  Yifei Lin; Deyi Luo; Banghua Liao; Tongxin Yang; Ye Tian; Tao Jin; Guiming Wang; Hongying Zhou; Hong Li; Kunjie Wang
Journal:  World J Urol       Date:  2018-03-14       Impact factor: 4.226

2.  Contemporary Management of Male Anterior Urethral Strictures by Reconstructive Urology Experts-Results from an International Survey among ESGURS Members.

Authors:  Felix Campos-Juanatey; Enrique Fes-Ascanio; Jan Adamowicz; Fabio Castiglione; Andrea Cocci; Guglielmo Mantica; Clemens Rosenbaum; Wesley Verla; Malte W Vetterlein; Marjan Waterloos; Luis A Kluth
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.241

3.  The spectrum of pelvic fracture urethral injuries and posterior urethroplasty in an Italian high-volume centre, from 1980 to 2013.

Authors:  Guido Barbagli; Salvatore Sansalone; Giuseppe Romano; Massimo Lazzeri
Journal:  Arab J Urol       Date:  2014-09-16

Review 4.  Simple perineal and elaborated perineal posterior urethroplasty.

Authors:  George D Webster; Andrew C Peterson
Journal:  Arab J Urol       Date:  2015-03-09

5.  Factors that influence the outcome of open urethroplasty for pelvis fracture urethral defect (PFUD): an observational study from a single high-volume tertiary care center.

Authors:  Qiang Fu; Yu-meng Zhang; Guido Barbagli; Jiong Zhang; Hong Xie; Ying-long Sa; San-bao Jin; Yue-min Xu
Journal:  World J Urol       Date:  2015-03-14       Impact factor: 4.226

6.  Surgical and Patient-Reported Outcomes of Delayed Anastomotic Urethroplasty for Male Pelvic Fracture Urethral Injury at a Japanese Referral Center.

Authors:  Akio Horiguchi; Masayuki Shinchi; Kenichiro Ojima; Yusuke Hirano; Keiichi Ito; Ryuichi Azuma
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

7.  Application of Wnt Pathway Inhibitor Delivering Scaffold for Inhibiting Fibrosis in Urethra Strictures: In Vitro and in Vivo Study.

Authors:  Kaile Zhang; Xuran Guo; Weixin Zhao; Guoguang Niu; Xiumei Mo; Qiang Fu
Journal:  Int J Mol Sci       Date:  2015-11-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.